0001185185-17-001572.txt : 20170720 0001185185-17-001572.hdr.sgml : 20170720 20170720163819 ACCESSION NUMBER: 0001185185-17-001572 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170720 DATE AS OF CHANGE: 20170720 EFFECTIVENESS DATE: 20170720 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BioSig Technologies, Inc. CENTRAL INDEX KEY: 0001530766 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 264333375 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-291219 FILM NUMBER: 17974672 BUSINESS ADDRESS: STREET 1: 8441 WAYZATA BLVD STREET 2: SUITE 240 CITY: MINNEAPOLIS STATE: MN ZIP: 55426 BUSINESS PHONE: 763-999-7330 MAIL ADDRESS: STREET 1: 8441 WAYZATA BLVD STREET 2: SUITE 240 CITY: MINNEAPOLIS STATE: MN ZIP: 55426 D 1 primary_doc.xml X0708 D LIVE 0001530766 BioSig Technologies, Inc. 8441 WAYZATA BLVD SUITE 240 MINNEAPOLIS MN MINNESOTA 55426 763-999-7330 DELAWARE None None Corporation true Kenneth Londoner 8441 Wayzata Blvd. Suite 240 Minneapolis MN MINNESOTA 55426 Executive Officer Director Chief Executive Officer and Director of the Issuer Steve Chaussy 8441 Wayzata Blvd. Suite 240 Minneapolis MN MINNESOTA 55426 Executive Officer Chief Financial Officer Donald Foley 8441 Wayzata Blvd. Suite 240 Minneapolis MN MINNESOTA 55426 Director Director Roy Tanaka 8441 Wayzata Blvd. Suite 240 Minneapolis MN MINNESOTA 55426 Director Director Jerome Zeldis 8441 Wayzata Blvd. Suite 240 Minneapolis MN MINNESOTA 55426 Director Director Patrick Gallagher 8441 Wayzata Blvd. Suite 240 Minneapolis MN MINNESOTA 55426 Director Director Seth Fischer 8441 Wayzata Blvd. Suite 240 Minneapolis MN MINNESOTA 55426 Director Director Jeffrey O'Donnell 8441 Wayzata Blvd. Suite 240 Minneapolis MN MINNESOTA 55426 Director Director David Weild 8441 Wayzata Blvd. Suite 240 Minneapolis MN MINNESOTA 55426 Director Director Biotechnology Decline to Disclose 06b false 2017-04-06 false true true false 15000 7000000 1640398 5359602 This represents aggregate consideration of $1,640,398 received in connection with the Issuer's closings occurring between April 6, 2017 and July 13, 2017. false 22 0 0 0 false BioSig Technologies, Inc. /s/ Kenneth Londoner Kenneth Londoner Executive Chairman and Chief Executive Officer 2017-07-20